J Periodontal Res:牙周健康和疾病患者中唾液Del-1, IL-17和LFA-1的水平分析

2020-04-13 lishiting MedSci原创

在牙周疾病中,Developmental endothelial locus-1 (Del-1), lymphocyte function-associated antigen-1 (LFA-1)和i

在牙周疾病中,Developmental endothelial locus-1 (Del-1), lymphocyte function-associated antigen-1 (LFA-1)和interleukin 17 (IL-17)对于中性白细胞跨内皮迁移的过程起到决定性作用。这篇研究的目的是为了评估牙龈炎(G), 慢性牙周炎(CP)和广泛性侵袭性牙周炎(GAP)患者的唾液Del-1, IL-17和LFA-1蛋白水平差异。

研究按照Armitage's (1999)分级共纳入180名身体健康、无吸烟史的患者(45名牙周健康(H)和45名G, 50名CP, 40名GAP)个体(在2014年3月至2016年2月)。记录临床牙周指标,包括临床附着水平、探诊深度、菌斑指数和牙龈指数。收集患者未受刺激下的唾液样本,通过酶联免疫吸附测定检测Del-1, IL-17和LFA-1的蛋白表达水平。采用Kruskal-Wallis和Mann-Whitney U检验分别实施多重比较和post hoc统计学分析。采用ROC曲线分析评估Del-1, IL-17和LFA-1的敏感性和特异性以区分牙周疾病与健康个体和牙龈炎患者。

结果显示,与G和H组相比,CP和GAP组IL-17水平增高,而Del-1水平降低(P < .001)。然而,GAP组中LFA-1水平明显高于CP或G组(P = .00)。相一致的,H和G组LFA-1水平明显低于CP和GAP组(P = .00)。3个生物标记物的联合应用可以作为最好的预测指标,它展现出最高的AUC [0.893, 0.845-0.94 (%95 CI) P < .001]以区别牙周疾病与健康个体和牙龈炎患者。

结论:唾液Del-1, LFA-1和IL-17水平可能是确定临床健康和牙周炎患者疾病状态的有益指标。然而,还需要更多的研究评估牙周治疗前后唾液Del-1, LFA-1和IL-17的水平变化以了解这些因子在牙周愈合过程中的确切作用。

原始出处:

Elif Inönü, Seyit Ali Kayis, et al. Salivary Del-1, IL-17, and LFA-1 Levels in Periodontal Health and Disease. J Periodontal Res., 2020 Mar 10[Online ahead of print]

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1799111, encodeId=dbb31e9911198, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Wed Jul 15 18:47:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764329, encodeId=fb511e64329d8, content=<a href='/topic/show?id=554b6e498a9' target=_blank style='color:#2F92EE;'>#牙周健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67498, encryptionId=554b6e498a9, topicName=牙周健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6537707026, createdName=12498c32m80暂无昵称, createdTime=Tue Oct 06 13:47:23 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728411, encodeId=399a1e2841144, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 21 06:47:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374438, encodeId=6cbb13e443831, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9638, encryptionId=1727963861, topicName=IL-17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451224, encodeId=19e71451224b1, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508274, encodeId=441915082e4be, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9624, encryptionId=8d4596248e, topicName=IL-1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6cf9946833, createdName=jjjiang0202, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381673, encodeId=faef3816e350, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/12/c342d58f35f7cda5722de560807a1eb8.jpg, createdBy=a37a5317256, createdName=1489e4e7m33暂无昵称, createdTime=Mon Apr 13 23:39:22 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381667, encodeId=a73138166eb7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 13 22:20:25 CST 2020, time=2020-04-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1799111, encodeId=dbb31e9911198, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Wed Jul 15 18:47:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764329, encodeId=fb511e64329d8, content=<a href='/topic/show?id=554b6e498a9' target=_blank style='color:#2F92EE;'>#牙周健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67498, encryptionId=554b6e498a9, topicName=牙周健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6537707026, createdName=12498c32m80暂无昵称, createdTime=Tue Oct 06 13:47:23 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728411, encodeId=399a1e2841144, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 21 06:47:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374438, encodeId=6cbb13e443831, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9638, encryptionId=1727963861, topicName=IL-17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451224, encodeId=19e71451224b1, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508274, encodeId=441915082e4be, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9624, encryptionId=8d4596248e, topicName=IL-1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6cf9946833, createdName=jjjiang0202, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381673, encodeId=faef3816e350, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/12/c342d58f35f7cda5722de560807a1eb8.jpg, createdBy=a37a5317256, createdName=1489e4e7m33暂无昵称, createdTime=Mon Apr 13 23:39:22 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381667, encodeId=a73138166eb7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 13 22:20:25 CST 2020, time=2020-04-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1799111, encodeId=dbb31e9911198, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Wed Jul 15 18:47:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764329, encodeId=fb511e64329d8, content=<a href='/topic/show?id=554b6e498a9' target=_blank style='color:#2F92EE;'>#牙周健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67498, encryptionId=554b6e498a9, topicName=牙周健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6537707026, createdName=12498c32m80暂无昵称, createdTime=Tue Oct 06 13:47:23 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728411, encodeId=399a1e2841144, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 21 06:47:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374438, encodeId=6cbb13e443831, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9638, encryptionId=1727963861, topicName=IL-17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451224, encodeId=19e71451224b1, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508274, encodeId=441915082e4be, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9624, encryptionId=8d4596248e, topicName=IL-1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6cf9946833, createdName=jjjiang0202, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381673, encodeId=faef3816e350, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/12/c342d58f35f7cda5722de560807a1eb8.jpg, createdBy=a37a5317256, createdName=1489e4e7m33暂无昵称, createdTime=Mon Apr 13 23:39:22 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381667, encodeId=a73138166eb7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 13 22:20:25 CST 2020, time=2020-04-13, status=1, ipAttribution=)]
    2020-04-21 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=1799111, encodeId=dbb31e9911198, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Wed Jul 15 18:47:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764329, encodeId=fb511e64329d8, content=<a href='/topic/show?id=554b6e498a9' target=_blank style='color:#2F92EE;'>#牙周健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67498, encryptionId=554b6e498a9, topicName=牙周健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6537707026, createdName=12498c32m80暂无昵称, createdTime=Tue Oct 06 13:47:23 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728411, encodeId=399a1e2841144, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 21 06:47:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374438, encodeId=6cbb13e443831, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9638, encryptionId=1727963861, topicName=IL-17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451224, encodeId=19e71451224b1, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508274, encodeId=441915082e4be, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9624, encryptionId=8d4596248e, topicName=IL-1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6cf9946833, createdName=jjjiang0202, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381673, encodeId=faef3816e350, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/12/c342d58f35f7cda5722de560807a1eb8.jpg, createdBy=a37a5317256, createdName=1489e4e7m33暂无昵称, createdTime=Mon Apr 13 23:39:22 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381667, encodeId=a73138166eb7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 13 22:20:25 CST 2020, time=2020-04-13, status=1, ipAttribution=)]
    2020-04-15 fzwish20000
  5. [GetPortalCommentsPageByObjectIdResponse(id=1799111, encodeId=dbb31e9911198, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Wed Jul 15 18:47:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764329, encodeId=fb511e64329d8, content=<a href='/topic/show?id=554b6e498a9' target=_blank style='color:#2F92EE;'>#牙周健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67498, encryptionId=554b6e498a9, topicName=牙周健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6537707026, createdName=12498c32m80暂无昵称, createdTime=Tue Oct 06 13:47:23 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728411, encodeId=399a1e2841144, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 21 06:47:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374438, encodeId=6cbb13e443831, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9638, encryptionId=1727963861, topicName=IL-17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451224, encodeId=19e71451224b1, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508274, encodeId=441915082e4be, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9624, encryptionId=8d4596248e, topicName=IL-1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6cf9946833, createdName=jjjiang0202, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381673, encodeId=faef3816e350, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/12/c342d58f35f7cda5722de560807a1eb8.jpg, createdBy=a37a5317256, createdName=1489e4e7m33暂无昵称, createdTime=Mon Apr 13 23:39:22 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381667, encodeId=a73138166eb7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 13 22:20:25 CST 2020, time=2020-04-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1799111, encodeId=dbb31e9911198, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Wed Jul 15 18:47:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764329, encodeId=fb511e64329d8, content=<a href='/topic/show?id=554b6e498a9' target=_blank style='color:#2F92EE;'>#牙周健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67498, encryptionId=554b6e498a9, topicName=牙周健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6537707026, createdName=12498c32m80暂无昵称, createdTime=Tue Oct 06 13:47:23 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728411, encodeId=399a1e2841144, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 21 06:47:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374438, encodeId=6cbb13e443831, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9638, encryptionId=1727963861, topicName=IL-17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451224, encodeId=19e71451224b1, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508274, encodeId=441915082e4be, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9624, encryptionId=8d4596248e, topicName=IL-1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6cf9946833, createdName=jjjiang0202, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381673, encodeId=faef3816e350, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/12/c342d58f35f7cda5722de560807a1eb8.jpg, createdBy=a37a5317256, createdName=1489e4e7m33暂无昵称, createdTime=Mon Apr 13 23:39:22 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381667, encodeId=a73138166eb7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 13 22:20:25 CST 2020, time=2020-04-13, status=1, ipAttribution=)]
    2020-04-15 jjjiang0202
  7. [GetPortalCommentsPageByObjectIdResponse(id=1799111, encodeId=dbb31e9911198, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Wed Jul 15 18:47:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764329, encodeId=fb511e64329d8, content=<a href='/topic/show?id=554b6e498a9' target=_blank style='color:#2F92EE;'>#牙周健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67498, encryptionId=554b6e498a9, topicName=牙周健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6537707026, createdName=12498c32m80暂无昵称, createdTime=Tue Oct 06 13:47:23 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728411, encodeId=399a1e2841144, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 21 06:47:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374438, encodeId=6cbb13e443831, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9638, encryptionId=1727963861, topicName=IL-17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451224, encodeId=19e71451224b1, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508274, encodeId=441915082e4be, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9624, encryptionId=8d4596248e, topicName=IL-1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6cf9946833, createdName=jjjiang0202, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381673, encodeId=faef3816e350, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/12/c342d58f35f7cda5722de560807a1eb8.jpg, createdBy=a37a5317256, createdName=1489e4e7m33暂无昵称, createdTime=Mon Apr 13 23:39:22 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381667, encodeId=a73138166eb7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 13 22:20:25 CST 2020, time=2020-04-13, status=1, ipAttribution=)]
    2020-04-13 1489e4e7m33暂无昵称

    谢谢

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1799111, encodeId=dbb31e9911198, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Wed Jul 15 18:47:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764329, encodeId=fb511e64329d8, content=<a href='/topic/show?id=554b6e498a9' target=_blank style='color:#2F92EE;'>#牙周健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67498, encryptionId=554b6e498a9, topicName=牙周健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6537707026, createdName=12498c32m80暂无昵称, createdTime=Tue Oct 06 13:47:23 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728411, encodeId=399a1e2841144, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 21 06:47:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374438, encodeId=6cbb13e443831, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9638, encryptionId=1727963861, topicName=IL-17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451224, encodeId=19e71451224b1, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508274, encodeId=441915082e4be, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9624, encryptionId=8d4596248e, topicName=IL-1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6cf9946833, createdName=jjjiang0202, createdTime=Wed Apr 15 12:47:23 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381673, encodeId=faef3816e350, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/12/c342d58f35f7cda5722de560807a1eb8.jpg, createdBy=a37a5317256, createdName=1489e4e7m33暂无昵称, createdTime=Mon Apr 13 23:39:22 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381667, encodeId=a73138166eb7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Apr 13 22:20:25 CST 2020, time=2020-04-13, status=1, ipAttribution=)]
    2020-04-13 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

Sci Rep:精液中的miRNAs可以作为前列腺癌诊断的非侵入性生物标记

尽管对前列腺组织是特异性的,血清前列腺特异性抗原(PSA)筛选经常导致前列腺癌的过度诊断和许多不必要的良性疾病活检,因此需要进一步的改善。最近,有研究人员对PSA水平适度提高的男性的精液的miRNAs表达水平进行了分析,从而评估其作为非侵入性生物标记来对PCa进行诊断和预后的应用价值。研究人员发现,高通量分析表明了PCa患者中miRNA表达模式与健康个体(HCt)相比发生了改变。研究人员考虑了输精

Oncogene:RASSF10在肾癌中经常表观遗传去激活且其敲除能够促进肿瘤形成

肾癌的发生率在全球范围内增加,因此迫切需要靶向治疗和精准医药。之前的研究鉴定和分析了包含10个成员的Ras相关结构域家族,且在人类癌症中经常异常表达。最近,有研究人员建立和分析了Rassf10敲除小鼠模型的相关情况。研究发现,Rassf10单倍体剂量不足能够促进两种小鼠模型(Rassf1A-/-和p53-/-)肿瘤的形成。单倍体剂量不足Rassf10敲除小鼠能够明显的导致各种倾向性疾病,包括淋巴瘤

Sci Rep:新诊断转移前列腺癌患者中血清生物标记早期变化的预后意义

最近,有研究人员评估了血清生物标记水平的早期变化对患有转移激素敏感性前列腺癌(mHSPC)患者生存的影响,且这些患者起初是通过雄激素阻断疗法(ADTR)来治疗的。研究人员回顾性的调查了330mHSPC患者在基线和2-4个月时的血清标记水平,并建立了最优Cox回顾模型。研究发现,癌症特异生存(CSS)均值和总生存(OS)均值分别为7.08年和6.42年(平均跟踪调查时间为2.53年)。在最终的最优C

J Clin Oncol:局部前列腺癌的分子生物标记:ASCO指南

最近,有研究人员提供了一个基于前列腺癌可利用生物标记的推荐指南,旨在改变积极监测患者的选择、临床显著疾病的鉴定、前列腺切除术后辅助治疗与挽救性放疗的选择、以及解决一些新出现的问题,比如组织生物标志物与核磁共振成像的相对值情况。研究人员共鉴定了555个相关的研究,选择了其中的77个加上专家小组选择的32个额外的参考。研究发现,很少的生物标记在多个群体中具有有效的测试结果,并且这些测试中只有5个目前已

Sci Rep:血清N-glycan是去势抵抗性前列腺的潜在生物标记

最近,有研究人员调查了血清N-glycan在去势抵抗性前列腺癌中的诊断和预后意义。研究人员回顾性的调查了287名良性前列腺增生(BPH)患者、289名新诊断前列腺癌(PC)患者、57名进行雄激素阻断治疗且无疾病恶化的PC患者(PC-ADT)和60名CRPC患者的糖印迹血清N-glycan结构分析情况,并比较了非CPRC患者(BPH、新诊断PC和PC-ADT)与CPRC患者的N-glycan情况。研

Clin Respir J:过敏性鼻炎和睡眠呼吸暂停综合征儿童共有的和特异的风险因子和临床生物标记研究

鼻炎和睡眠呼吸暂停综合征(OSAS)是不同的疾病,但是具有相似的风险因子。最近,有研究人员比较了鼻炎和OSAS儿童中的风险因子和临床生物标记情况。研究是一个代表性的研究,包括了3917名儿童(4-13岁)。研究发现,OSAS和鼻炎在研究群体中的患病率分别为4.0%和43.5%。身体质量指数(P<0.001)和早熟(P=0.016)与OSAS显著相关,而与鼻炎没有相关性。父母更高的教育水平和收